SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-17-029439
Filing Date
2017-07-31
Accepted
2017-07-31 18:19:52
Documents
2
Period of Report
2017-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 4972
2 poa_crandell.htm EX-24.1 7075
  Complete submission text file 0001140361-17-029439.txt   13725
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 7733806600
ARCH Venture Partners VIII, LLC (Reporting) CIK: 0001616165 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-38155 | Film No.: 17994174

Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Issuer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations